期刊文献+

IL-32在大鼠心肌细胞缺氧损伤中的作用及其机制 被引量:1

Roles and Mechanisms of Interleukin-32 on Rat Cardiomyocytes with Hypoxia Injury
下载PDF
导出
摘要 目的:探讨IL-32在大鼠心肌细胞缺氧损伤中的作用及其机制。方法:构建乳鼠心肌细胞缺氧模型后,比较缺氧组与正常组IL-32、IL-1β、IL-6、IL-18、TNF-α和IL-10 mRNA及蛋白水平的表达情况,以及IL-32与各细胞因子间的相关性。结果:与正常组相比,缺氧组心肌细胞坏死明显;IL-32、IL-1β、IL-6、IL-18、TNF-α和IL-10基因及蛋白表达水平均明显升高;Pearson相关分析提示IL-32与IL-1β、IL-6、IL-18、TNF-α和IL-10水平呈正相关。结论:大鼠心肌细胞缺氧后,IL-32表达水平明显升高;IL-32与传统细胞因子IL-1β、IL-6、IL-18、TNF-α和IL-10表达水平呈正相关。 Objective: To investigate the roles and mechanisms of interleukin-32 (IL-32) on rat cardiomyo- cytes with hypoxia injury. Methods: When eardiomyocytes with hypoxia injury was produced, mRNA and protein levels of IL-32, IL-1 [3, IL-6, IL-18, TNF-α and IL-10 were compared between hypoxia group and control group. The relationships of IL-32 with other factors were also evaluated. Results: When compared with control group, number of apoptotic cardiomyocytes was significantly higher, accompanied with higher levels of mRNA and proteins of IL-32, IL-1β, IL-6, IL-18, TNF-α and IL-10. As indicated by the Pearson correlation analysis, IL-32 was pos- itively correlated with IL-113, IL-6, IL-18, TNF-α and IL-10. Conclusion: 1L-32 was significantly increased after insulted by hypoxia injury in rat eardiomyocytes, and IL-32 was positively correlated with inflammatory factors such as IL-1β, IL-6, IL-1β, TNF-α and IL-IO.
出处 《新医学》 2013年第4期282-284,共3页 Journal of New Medicine
基金 2012年深圳市科技计划项目(201203048)
关键词 白细胞介素-32 心肌细胞 缺氧 Interleukin-32 Cardiomyoeytes Hypoxia
  • 相关文献

参考文献3

二级参考文献48

  • 1OKURA H,MATSUYAMA A,LEE C M,et al.Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model[J].Tissue Eng Part C Methods,2009,[Epub ahead of print].
  • 2SHI R Z,LI Q P.Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease[J].Biochem Biophys Res Commun,2008,376(2):247-250.
  • 3DAVIGNON J.Beneficial cardiovascular pleiotropic effects of statins[J].Circulation,2004,109(23 Suppl 1):III39-III43.
  • 4ETO M,L(U)SCHER T F.The cardioprotective effects of statins[J].Coron Artery Dis,2004,15(5):243-245.
  • 5MUNK P S,LARSEN A I.Inflammation and C-reactive protein in cardiovascular disease[J].Tidsskr Nor Laegeforen,2009,129(12):1221-1224.
  • 6BLUM A,SHAMBUREK R.The pleiotropic effects of statins on endothelial function,vascular inflammation,immunomodulation and thrombogenesis[J].Atherosclerosis,2009,203(2):325-330.
  • 7RIDKER P M,SILVERTOWN J D.Inflammation,C-reactive protein,and atherothrombosis[J].J Periodontol,2008,79(8 Suppl):1544-1551.
  • 8GELOSA P,CIMINO M,PIGNIERI A,et al.The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation[J].Vasc Health Risk Manag,2007,3(5):567-577.
  • 9MATSUNO H,TAKEI M,HAYASHI H,et al.Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries[J].J Cardiovasc Pharmacol,2004,43(3):333-340.
  • 10BHATT D L.Anti-inflammatory agents and antioxidants as a possible "third great wave"in cardiovascular secondary prevention[J].Am J Cardiol,2008,101(10A):4D-13D.

共引文献24

同被引文献14

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部